Expression of CCR-7, MIP-3β, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: Importance for the rapid acquisition of potent migratory and functional activities

Blood

Volumn 98, Issue 10, 2001, Pages 3022-3029

  Parlato, Stefania ^a   Santini, Stefano M ^a   Lapenta, Caterina ^a   Di Pucchio, Tiziana ^a   Logozzi, Mariantonia ^a   Spada, Massimo ^a   Giammarioli, Anna Maria ^a   Malorni, Walter ^a   Fais, Stefano ^a   Belardelli, Filippo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD83 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERFERON; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; MONOCYTE; MORPHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TH1 CELL;

EID: 17644449715     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.10.3022     Document Type: Article

References (54)

1. Steinman R-M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
2. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation, and antigen-presenting function of dendritic cells. Curr Opin Immunol. 1997;9:10-16.
3. Banchereau J, Steinman R-M. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
4. Dieu-Nosjean M-C, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leuk Biol. 1999;66:252-262.
5. Sozzani S, Allavena P, Vecchi A, Mantovani A. Chemokines and dendritic cell traffic. J Immunol. 2000:20:151-160.
6. Oppenheim J-J. Overview of chemokines. Adv Exp Med Biol. 1993;351:183-186.
7. Schall T-J, Bacon K-B. Chemokines, leukocyte trafficking and inflammation. Curr Opin Immunol. 1994;6:865-873.
8. Sozzani S, Allavena P, D'Amico G, et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998;161:1083-1086.
9. Sallusto F, Schaerli P, Loetscher P, et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998;28:2760-2769.
10. Dieu M-C, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373- 386.
11. Delgado E, Finkel V, Baggiolini M, Mackay C-R, Steinman R-M, Granelli-Piperno A. Mature dendritic cells respond to SDF-1 but not to several beta-chemokines. Immunobiology. 1998;198:490-500.
12. Lin C-L, Suri R-M, Rahdon R-A, Austyn J-M, Roake J-A. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur J Immunol. 1998;28:4114-4122.
13. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing function in secondary lymphoid organs. Cell. 1999;99:23-33.
14. Zhou L, Tedder T-F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 1995;154:3821-3835.
15. + monocytes are dendritic cells. J Immunol. 1999;163:5920-5928.
16. Adams D-H, Shaw S. Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet. 1994;343:831-836.
17. Springer T-A. Traffic signals for lymphocytes recirculation and leukocyte migration: the multistep paradigm. Cell. 1994;76:301-314.
18. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109-1118.
19. Randolph G-J, Beaulieu S, Lebecque S, Steinman R-M, Muller W-A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 1998;282:480-483.
20. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS. 1995;103:161-179.
21. Biron C-A, Nguyen K-B, Pien G-C, Cousens L-P, Salazar-Mather T-P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.
22. Tough D-F, Borrow P, Sprent J. Induction of by-stander T cell proliferation by viruses and type I interferon in vivo. Science. 1996;272:1947-1950.
23. + T cells after injection of tumor cells expressing IFN-α into syngenic mice. Cancer Res. 1998;58:5795-5802.
24. Sun S, Zhang X, Tough D-F, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med. 1998;188:2335-2342.
25. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 1999;189:530-531.
26. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today. 1992;13:379-381.
27. Belardelli F, Gresser I. The neglected role of type I interferon in the T cell response: implications for its clinical use. Immunol Today. 1996;17:369-372.
28. Rogge L, Barberis-Maino L, Biffi M, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 1997;185:825-831.
29. Siegal F-P, Kadowaki N, Shodell M, et al. The nature of the principal type I interferon-producing cells in human blood. Science. 1999;284:1835-1837.
30. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.
31. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat Immunol. 2000;1:305-310.
32. Paquette R-L, Hsu N-C, Kiertscher S-M, et al. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol. 1998;64:358-367.
33. Radvanyi L-G, Banerjee A, Weir M, Messner H. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand J Immunol. 1999;50:499-500.
34. Santini S-M, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-scid mice. J Exp Med. 2000;191:1777-1788.
35. Alton K, Stabinsky Y, Richards R, et al. Production, characterization and biological effects of recombinant DNA derived human IFN-α and IFN-γ analogs. In: De Maeyer E, Schellenkens H, eds. The Biology of the Interferon System. Amsterdam, The Netherlands: Elsevier; 1983:119-128.
36. Fais S, Capobianchi M-R, Abbate I, et al. Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS. 1995;9:329-335.
37. Sato K, Kawasaki H, Nagayama H, et al. CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. Blood. 1999;93:34-42.
38. Sato K, Kawasaki H, Nagayama H, et al. TGF-β1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol. 2000;164:2285-2295.
39. Rizza P, Santini S-M, Logozzi M-A, et al. T-cell dysfunction in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. J Virol. 1996;70:7958-7964.
40. Rossio J-L, Esser M-T, Suryanarayana K, et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol. 1998;72:7992-8001.
41. Adema G-J, Hartgers F, Verstraten R, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive cells. Nature. 1997;387:713-717.
42. Sallusto F, Lenig D, Mackay C-R, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875-883.
43. Qin S, Rottman J-B, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101:746-754.
44. Andrew D-P, Chang M-S, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokine IL-4 and IL-13. J Immunol. 1998;161:5027-5038.
45. Lesley J, Hyman R, Kincade P-W. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335.
46. Haegel-Kronenberger H, de la Salle H, Bohbot A, Oberling F, Cazenave J-P, Hanau D. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. J Immunol. 1998;161:3902-3911.
47. Fais S, Burgio V-L, Capobianchi M-R, Gessani S, Pallone F, Belardelli F. The biological relevance of polykaryons in the immune response. Immunol Today. 1997;18:522-527.
48. del Pozo M-A, Sanchez-Mateos P, Sanchez-Madrid F. Cellular polarization induced by chemokines: a mechanism for leukocyte recruitment? Immunol Today. 1996;17:127-131.
49. Armitage R-J, Macduff B-M, Eisenman J, Paxton R, Grabstein K-H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol. 1995;154:483-490.
50. Gunn M-D, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med. 1999;189:451- 460.
51. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nat Immunol. 2000;1:311-316.
52. Thurnher M, Zelle-Rieser C, Ramoner R, Bartsch G, Holtl L. The disabled dendritic cell. FASEB J. 2001;15:1054-1061.
53. + precursors. Blood. 2000;96:210-217.
54. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough D-F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 2001;14:461-470.